ASHLEY TANNHOF: Open Payments
NPI 1386265379 · ORRVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 36 payments from 12 companies in 2025. Trend: 2023 $145 · 2024 $727 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $198 |
| Novo Nordisk Inc | 4 | $148 |
| Alkermes, Inc. | 2 | $127 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
| Xeris Pharmaceuticals, Inc. | 3 | $97 |
| Corcept Therapeutics | 2 | $47 |
| Indivior Inc. | 2 | $39 |
| Organon LLC | 2 | $34 |
| Lilly USA, LLC | 2 | $31 |
| Optinose US, Inc. | 1 | $28 |
Products named: VIVITROL, Ozempic, UBRELVY, INGREZZA, GVOKE HYPOPEN, Korlym, SUBLOCADE, QULIPTA.
Industry payments across OH — which companies pay providers there.
